Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04389866 · ClinicalTrials.gov registry record · NA
Jowl Improvement With Injectable Fillers
A NA study, sponsored by Advanced Dermatology.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04389866 is a NA study that has completed, run by Advanced Dermatology. The registered enrollment target is 16 participants.
The verdict
NCT04389866, a NA study, has completed, sponsored by Advanced Dermatology.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a prospective clinical study to demonstrate a reduction in jowling and laxity of the jawline that can be achieved following facial volume enhancement using JUVÉDERM VOLUMA™ XC (0.3% w/w lidocaine). The secondary measure will be if this can be achieved with Jawline injection only, or if a superior result can be obtained with both cheek and jowl injection.
Interventions
- DEVICE JUVÉDERM VOLUMA™ XC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2022-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04389866
The ClinicalTrials.gov registry entry for NCT04389866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advanced Dermatology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JUVÉDERM VOLUMA™ XC is the first listed.
NCT04389866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04389866 about?
NCT04389866 is a clinical study titled "Jowl Improvement With Injectable Fillers". This is a prospective clinical study to demonstrate a reduction in jowling and laxity of the jawline that can be achieved following facial volume enhancement using JUVÉDERM VOLUMA™ XC (0.3% w/w lidocaine). The secondary measure will be if this can be achieved with Jawline injection only, or if a sup...
What is the current status of trial NCT04389866?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2020-09-25. Estimated completion is 2022-10-05.
What interventions are being tested in trial NCT04389866?
The interventions under investigation include: JUVÉDERM VOLUMA™ XC (DEVICE).
Who is sponsoring clinical trial NCT04389866?
This trial is sponsored by Advanced Dermatology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.